DK2665512T3 - Intragastrisk indretning - Google Patents
Intragastrisk indretning Download PDFInfo
- Publication number
- DK2665512T3 DK2665512T3 DK11856347.7T DK11856347T DK2665512T3 DK 2665512 T3 DK2665512 T3 DK 2665512T3 DK 11856347 T DK11856347 T DK 11856347T DK 2665512 T3 DK2665512 T3 DK 2665512T3
- Authority
- DK
- Denmark
- Prior art keywords
- balloon
- inflation
- catheter
- volume
- inflating
- Prior art date
Links
- 239000000463 material Substances 0.000 claims description 216
- 238000007789 sealing Methods 0.000 claims description 73
- 239000012530 fluid Substances 0.000 claims description 68
- 230000007246 mechanism Effects 0.000 claims description 44
- 230000004888 barrier function Effects 0.000 claims description 38
- 239000002775 capsule Substances 0.000 claims description 37
- -1 polyethylene Polymers 0.000 claims description 37
- 239000004677 Nylon Substances 0.000 claims description 26
- 229920001778 nylon Polymers 0.000 claims description 26
- 238000001727 in vivo Methods 0.000 claims description 25
- 210000003238 esophagus Anatomy 0.000 claims description 19
- 239000004698 Polyethylene Substances 0.000 claims description 18
- 229920000573 polyethylene Polymers 0.000 claims description 18
- 229920001296 polysiloxane Polymers 0.000 claims description 15
- 230000009977 dual effect Effects 0.000 claims description 14
- 238000007906 compression Methods 0.000 claims description 11
- 230000006835 compression Effects 0.000 claims description 11
- 108010010803 Gelatin Proteins 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 9
- 235000019322 gelatine Nutrition 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- 238000005299 abrasion Methods 0.000 claims description 8
- 238000004891 communication Methods 0.000 claims description 8
- 230000001965 increasing effect Effects 0.000 claims description 8
- 239000005033 polyvinylidene chloride Substances 0.000 claims description 6
- 229920001328 Polyvinylidene chloride Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 208000025865 Ulcer Diseases 0.000 claims description 2
- 210000004877 mucosa Anatomy 0.000 claims description 2
- 230000036269 ulceration Effects 0.000 claims description 2
- 238000005192 partition Methods 0.000 claims 7
- 238000005086 pumping Methods 0.000 claims 4
- 241001343274 Dichrostachys spicata Species 0.000 claims 2
- 239000007789 gas Substances 0.000 description 110
- 239000010410 layer Substances 0.000 description 98
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 86
- 238000000034 method Methods 0.000 description 66
- 210000002784 stomach Anatomy 0.000 description 64
- 230000002496 gastric effect Effects 0.000 description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 51
- 239000002131 composite material Substances 0.000 description 49
- 239000007788 liquid Substances 0.000 description 45
- 239000001569 carbon dioxide Substances 0.000 description 43
- 229910002092 carbon dioxide Inorganic materials 0.000 description 43
- 239000003795 chemical substances by application Substances 0.000 description 39
- 230000003628 erosive effect Effects 0.000 description 32
- 239000000203 mixture Substances 0.000 description 31
- 238000000576 coating method Methods 0.000 description 28
- 230000008569 process Effects 0.000 description 24
- 230000009747 swallowing Effects 0.000 description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 22
- 230000004913 activation Effects 0.000 description 21
- 238000006731 degradation reaction Methods 0.000 description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- 239000000853 adhesive Substances 0.000 description 18
- 230000001070 adhesive effect Effects 0.000 description 18
- 230000015556 catabolic process Effects 0.000 description 18
- 229920000139 polyethylene terephthalate Polymers 0.000 description 18
- 239000005020 polyethylene terephthalate Substances 0.000 description 18
- 239000011248 coating agent Substances 0.000 description 17
- 210000003128 head Anatomy 0.000 description 17
- 239000007924 injection Substances 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- 238000002347 injection Methods 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 238000011081 inoculation Methods 0.000 description 13
- 239000003550 marker Substances 0.000 description 13
- 230000037361 pathway Effects 0.000 description 13
- 230000035699 permeability Effects 0.000 description 13
- 229920002635 polyurethane Polymers 0.000 description 13
- 239000004814 polyurethane Substances 0.000 description 13
- 230000005540 biological transmission Effects 0.000 description 12
- 235000013305 food Nutrition 0.000 description 12
- 230000000670 limiting effect Effects 0.000 description 12
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 12
- 239000004696 Poly ether ether ketone Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 229920002530 polyetherether ketone Polymers 0.000 description 11
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 10
- 229920003023 plastic Polymers 0.000 description 10
- 239000004033 plastic Substances 0.000 description 10
- 229910052814 silicon oxide Inorganic materials 0.000 description 10
- 125000006850 spacer group Chemical group 0.000 description 10
- 239000010935 stainless steel Substances 0.000 description 10
- 229910001220 stainless steel Inorganic materials 0.000 description 10
- 238000012800 visualization Methods 0.000 description 10
- 239000004372 Polyvinyl alcohol Substances 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 238000009792 diffusion process Methods 0.000 description 9
- 229920002451 polyvinyl alcohol Polymers 0.000 description 9
- 210000001187 pylorus Anatomy 0.000 description 9
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 8
- 230000000903 blocking effect Effects 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 229920006298 saran Polymers 0.000 description 8
- 230000002269 spontaneous effect Effects 0.000 description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 7
- 229940035674 anesthetics Drugs 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000003193 general anesthetic agent Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 239000010703 silicon Substances 0.000 description 7
- 229910052710 silicon Inorganic materials 0.000 description 7
- 229910052709 silver Inorganic materials 0.000 description 7
- 239000004332 silver Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 6
- 229920000299 Nylon 12 Polymers 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 6
- 229960004106 citric acid Drugs 0.000 description 6
- 239000000470 constituent Substances 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000030136 gastric emptying Effects 0.000 description 6
- 230000030135 gastric motility Effects 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- 239000010931 gold Substances 0.000 description 6
- 239000004626 polylactic acid Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- 229910052719 titanium Inorganic materials 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- 230000004308 accommodation Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000593 degrading effect Effects 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 239000007903 gelatin capsule Substances 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 229920001610 polycaprolactone Polymers 0.000 description 5
- 239000004632 polycaprolactone Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 239000002356 single layer Substances 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229920002614 Polyether block amide Polymers 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 229940035676 analgesics Drugs 0.000 description 4
- 239000000730 antalgic agent Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000007667 floating Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000011261 inert gas Substances 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 229910000510 noble metal Inorganic materials 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000004800 polyvinyl chloride Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- 229920002292 Nylon 6 Polymers 0.000 description 3
- 229920002732 Polyanhydride Polymers 0.000 description 3
- 239000004642 Polyimide Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 229920001218 Pullulan Polymers 0.000 description 3
- 239000004373 Pullulan Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 229910052788 barium Inorganic materials 0.000 description 3
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000032798 delamination Effects 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 239000007888 film coating Substances 0.000 description 3
- 238000009501 film coating Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 229910052734 helium Inorganic materials 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229910052743 krypton Inorganic materials 0.000 description 3
- 229920000092 linear low density polyethylene Polymers 0.000 description 3
- 239000004707 linear low-density polyethylene Substances 0.000 description 3
- 229920001684 low density polyethylene Polymers 0.000 description 3
- 239000004702 low-density polyethylene Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000000065 osmolyte Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 3
- 229920000052 poly(p-xylylene) Polymers 0.000 description 3
- 239000011112 polyethylene naphthalate Substances 0.000 description 3
- 229920001721 polyimide Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 235000019423 pullulan Nutrition 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000004544 sputter deposition Methods 0.000 description 3
- 229920002725 thermoplastic elastomer Polymers 0.000 description 3
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 3
- 229920001187 thermosetting polymer Polymers 0.000 description 3
- 238000007740 vapor deposition Methods 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- SCRCZNMJAVGGEI-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;oxepan-2-one Chemical compound O=C1COC(=O)CO1.O=C1CCCCCO1 SCRCZNMJAVGGEI-UHFFFAOYSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- 244000186892 Aloe vera Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QTGIAADRBBLJGA-UHFFFAOYSA-N Articaine Chemical compound CCCNC(C)C(=O)NC=1C(C)=CSC=1C(=O)OC QTGIAADRBBLJGA-UHFFFAOYSA-N 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- 229920010126 Linear Low Density Polyethylene (LLDPE) Polymers 0.000 description 2
- 229920000106 Liquid crystal polymer Polymers 0.000 description 2
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 2
- 239000005041 Mylar™ Substances 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 229920001710 Polyorthoester Polymers 0.000 description 2
- 241000206607 Porphyra umbilicalis Species 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 2
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 229960004543 anhydrous citric acid Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 229960003831 articaine Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229910052729 chemical element Inorganic materials 0.000 description 2
- 229940099062 chloraseptic Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 238000001839 endoscopy Methods 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 2
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 210000005095 gastrointestinal system Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 229960005015 local anesthetics Drugs 0.000 description 2
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000020825 overweight Nutrition 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229950010732 poliglecaprone Drugs 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 229920000848 poly(L-lactide-ε-caprolactone) Polymers 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920001306 poly(lactide-co-caprolactone) Polymers 0.000 description 2
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 2
- 229920006260 polyaryletherketone Polymers 0.000 description 2
- 229920009537 polybutylene succinate adipate Polymers 0.000 description 2
- 239000004630 polybutylene succinate adipate Substances 0.000 description 2
- 239000000622 polydioxanone Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920006267 polyester film Polymers 0.000 description 2
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000002952 polymeric resin Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 229960004919 procaine Drugs 0.000 description 2
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000002210 silicon-based material Substances 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011973 solid acid Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 229960002372 tetracaine Drugs 0.000 description 2
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 229950002569 trimecaine Drugs 0.000 description 2
- GOZBHBFUQHMKQB-UHFFFAOYSA-N trimecaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=C(C)C=C1C GOZBHBFUQHMKQB-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 238000004260 weight control Methods 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 229920001634 Copolyester Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 208000008279 Dumping Syndrome Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229920000271 Kevlar® Polymers 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000032395 Post gastric surgery syndrome Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- PRQRQKBNBXPISG-UHFFFAOYSA-N chromium cobalt molybdenum nickel Chemical compound [Cr].[Co].[Ni].[Mo] PRQRQKBNBXPISG-UHFFFAOYSA-N 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000012611 container material Substances 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 208000018459 dissociative disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007897 gelcap Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 229940021223 hypertonic solution Drugs 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000004761 kevlar Substances 0.000 description 1
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 239000012633 leachable Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000012802 nanoclay Substances 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000520 poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Polymers 0.000 description 1
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229940094025 potassium bicarbonate Drugs 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001175 rotational moulding Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 229960001407 sodium bicarbonate Drugs 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- UISARWKNNNHPGI-UHFFFAOYSA-N terodiline Chemical compound C=1C=CC=CC=1C(CC(C)NC(C)(C)C)C1=CC=CC=C1 UISARWKNNNHPGI-UHFFFAOYSA-N 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
- 239000000602 vitallium Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0089—Instruments for placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10181—Means for forcing inflation fluid into the balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10184—Means for controlling or monitoring inflation or deflation
- A61M25/10185—Valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Nursing (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Surgical Instruments (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Claims (15)
1. System til oppumpning af en intragastrisk ballon, systemet omfatter: et oppumpningskateter (820), hvori oppumpningskateteret (820) omfatter en nålemontage, der omfatter en hul nål (1100), en klokkeformet nålebøsning (1000), og en mekanisme til at frigøre oppumpningskateteret (820), efter at oppumpningen af en ballon in vivo er fuldført; en introgastrisk ballon, der omfatter en polymer væg, hvori den polymere væg omfatter et eller flere lag, og et ballonventilsystem (100), der omfatter en selvtætnende skillevæg (114) i en holdestruktur, hvori skillevæggen (114) er konfigureret til at blive perforeret af nålen (1100), hvori holdestrukturen omfatter et koncentrisk ventilsystem med en mindre indvendig cylinder (118’), der huser skillevæggen (114), og en større udvendig cylinder (118”), der huser et hovedelement (110), der tilvejebringer trykkræfter mod den klokkeformede nålebøsning (1000) på oppumpningskateteret (820) til oppumpning og frigøring, hvori hovedelementet (110) til at tilvejebringe trykkræfterne, er af et hårdere materiale når målt med durometer end skillevæggen (114), og hvori hovedelementet (110) omfatter en læbe (110’), som er konfigureret til indgrebspasning med den klokkeformede nålebøsning (1000) for mellem ventilen (100) og oppumpningskateteret (820) at tilvejebringe tætning, der er tilstrækkelig til at tætningen kan blive bibeholdt under oppumpning af ballonen, en ydre ballon beholder (810), og en oppumpningskildebeholder (1410), hvori oppumpningskildebeholderen er konfigureret til at blive forbundet med oppumpningskateteret (820); hvori oppumpningskateteret (820), som er forbundet med den introgastriske ballon, før oppumpningen har en størrelse og form, som er konfigureret til at blive slugt af en patient, der er nødt til at gøre det.
2. System ifølge krav 1, hvori den polymere væg omfatter et barrieremateriale, der omfatter nylon/polyethylen.
3. System ifølge krav 1, hvori den polymere væg omfatter et barrieremateriale, der omfatter nylon/polyvinylidenchlorid/ polyethylen.
4. System ifølge krav 1, hvori den ydre beholder (810) er valgt fra gruppen, som består af en push-fit kapsel, en indpakning, og et bånd, og hvori den ydre beholder omfatter et materiale valgt ud fra gruppen, der består af, gelatine, cellulose og collagen.
5. System ifølge krav 1, hvori skillevæggen er konusformet.
6. System ifølge krav 1, hvori oppumpningskildebeholderen (1410) er konfigureret til at blive forbundet med oppumpningskateteret (820) via et forbindelseselement (1420) eller en oppumpningsventil (1470).
7. System ifølge krav 1, hvori oppumpningskateteret (820) er fra 1 French til 6 French i diameter, og er fra omkring 50 cm til omkring 60 cm i længde.
8. System ifølge krav 1, hvori oppumpningskateteret (820) er et dobbeltlumenkateter (920), der omfatter et oppumpningslumen (821) og et frigørelseslumen (822), hvori oppumpningslumenet (821) står i fluidforbindelse med oppumpningskildebeholderen (1410), og hvori frigørelseslumenet (822) er konfigureret til at blive forbundet med en frigørelsesvæskekildebeholder, hvori frigørelsesvæsken omfatter en fysiologisk kompatibel væske, og hvori indgrebspasningen er utilstrækkelig til at kunne bevare en tætning, efter at der med frigørelsesvæsken er tilført et hydraulisk tryk, således at nålemontagen ved tilførsel af det hydrauliske tryk stødes ud af ballonventilen (100).
9. System ifølge krav 1, hvori oppumpningskateteret (820) omfatter et enkelt lumen og en trækline (1120) til at tilvejebringe forøget trækstyrke, og en oppumpningsventil, der er konfigureret til at forbinde det enkelte lumen med oppumpningskildebeholderen (1410) og en frigørelsesvæskekildebeholder, hvori frigørelsesvæsken omfatter en fysiologisk kompatibel væske, og hvori indgrebspasningen er utilstrækkelig til at kunne bevare en tætning, efter at der med frigørelsesvæsken er tilført et hydraulisk tryk, således at nålemontagen ved tilførsel af det hydrauliske tryk stødes ud af ballonventilen (100).
10. System ifølge krav 1, hvori den indvendige cylinder (118’) er konfigureret til at styre den lineære opretning af nålemontagen i forhold til skillevæggen (114), tilvejebringe en barriere for nålens (1100) perforering af den polymere væg, og tilvejebringe kompression, således at skillevæggen (114) tætnes igen efter oppumpning og tilbagetrækning af nålen (1100).
11. System ifølge krav 1, hvori et antal introgastriske balloner er forbundet med et enkelt oppumpningskateter (820).
12. System ifølge krav 1, hvori oppumpningskateteret har en variabel stivhed (1300).
13. System ifølge krav 1, hvori oppumpningskilden omfatter en sprøjte (710).
14. System ifølge krav 1, hvori oppumpningskilden er konfigureret til at benytte information om oppumpningstrykket som funktion af tiden til at skaffe feedback til en bruger, hvori feedbacken indikerer en tilstand, som er valgt fra gruppen, der består af fejl som følge af mekanisk blokering, fejl som følge af indsnævring af spiserøret, fejl som følge af lækage af oppumpningskateteret eller af frigørelsen, og vellykket oppumpning af ballonen.
15. System ifølge krav 1, hvori læben (110’) er af silikone og ikke rager længere ud fra ballonens overflade end 2 mm for at sikre, at ballonens overflade forbliver forholdsvis glat og ikke forårsager slid eller sårdannelse på slimhinden.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/022165 WO2012099609A1 (en) | 2011-01-21 | 2011-01-21 | Intragastric device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2665512T3 true DK2665512T3 (da) | 2016-10-10 |
Family
ID=46516002
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16176405.5T DK3117865T3 (da) | 2011-01-21 | 2011-01-21 | Intragastrisk anordning |
| DK11856347.7T DK2665512T3 (da) | 2011-01-21 | 2011-01-21 | Intragastrisk indretning |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16176405.5T DK3117865T3 (da) | 2011-01-21 | 2011-01-21 | Intragastrisk anordning |
Country Status (12)
| Country | Link |
|---|---|
| US (10) | US8740927B2 (da) |
| EP (4) | EP2665512B1 (da) |
| KR (4) | KR101806089B1 (da) |
| AR (1) | AR085085A1 (da) |
| BR (1) | BR112013018254B1 (da) |
| DK (2) | DK3117865T3 (da) |
| ES (2) | ES2653806T3 (da) |
| HU (2) | HUE035460T2 (da) |
| MX (1) | MX345691B (da) |
| NO (1) | NO3117865T3 (da) |
| PT (2) | PT2665512T (da) |
| WO (1) | WO2012099609A1 (da) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010045477A2 (en) | 2008-10-16 | 2010-04-22 | Obalon Therapeutics, Inc. | Intragastric volume-occupying device and method for fabricating same |
| PT2665512T (pt) | 2011-01-21 | 2016-08-29 | Obalon Therapeutics Inc | Dispositivo intragástrico |
| US10182932B2 (en) | 2012-02-21 | 2019-01-22 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| RU2601995C2 (ru) | 2012-02-21 | 2016-11-10 | Аллюрион Текнолоджиз, Инк. | Способы и устройство для внедрения временного имплантата в тело и извлечения временного имплантата из тела |
| US9849018B2 (en) | 2012-02-21 | 2017-12-26 | Allurion Technologies, Inc. | Ingestible delivery systems and methods |
| DK2858604T3 (da) | 2012-06-07 | 2024-05-21 | Epitomee Medical Ltd | Ekspanderet anordning |
| US10137023B2 (en) | 2012-09-14 | 2018-11-27 | Medibotics Llc | Colonnade (TM) expandable intragastric food flow lumen device |
| AU2013381897B2 (en) * | 2013-03-15 | 2018-04-19 | Obalon Therapeutics, Inc. | Intragastric device |
| CN105960261A (zh) | 2013-12-04 | 2016-09-21 | 奥巴隆治疗公司 | 用于定位和/或表征胃内设备的系统和方法 |
| US11129793B2 (en) | 2013-12-05 | 2021-09-28 | Epitomee Medical Ltd | Retentive devices and systems for in-situ release of pharmaceutical active agents |
| WO2016057716A1 (en) | 2014-10-09 | 2016-04-14 | Obalon Therapeutics, Inc. | Ultrasonic systems and methods for locating and /or characterizing intragastric devices |
| US10335303B2 (en) | 2015-12-07 | 2019-07-02 | Obalon Therapeutics, Inc. | Intragastric device |
| US10537453B2 (en) | 2015-12-16 | 2020-01-21 | Obalon Therapeutics, Inc. | Intragastric device with expandable portions |
| US10350100B2 (en) | 2016-04-12 | 2019-07-16 | Obalon Therapeutics, Inc. | System for detecting an intragastric balloon |
| US10772752B2 (en) | 2016-11-04 | 2020-09-15 | Obalon Therapeutics, Inc. | Pressure control system for intragastric device |
| JP6285067B2 (ja) * | 2017-05-22 | 2018-02-28 | オバロン・セラピューティクス、インコーポレイテッドＯｂａｌｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | 胃内デバイス |
| US20180344993A1 (en) * | 2017-05-31 | 2018-12-06 | Robert A. Ganz | Blockage clearing devices, systems, and methods |
| US10537454B2 (en) | 2017-06-16 | 2020-01-21 | Proximate Concepts Llc | Electrophysiologically active transducer intragastric balloon system and method |
| WO2019018854A1 (en) * | 2017-07-21 | 2019-01-24 | Gi Dynamics, Inc. | SEGMENTED GASTROINTESTINAL DEVICES AND METHODS OF USE |
| WO2019022946A1 (en) * | 2017-07-24 | 2019-01-31 | Obalon Therapeutics, Inc. | SYSTEMS AND METHODS FOR LOCATING AND / OR CHARACTERIZING INTRAGASTRIC DEVICES |
| US10238516B1 (en) * | 2017-11-01 | 2019-03-26 | Barix Medical Corp. | Simplified implantable gastric balloon system with self deflating timer |
| US11083581B2 (en) * | 2017-12-04 | 2021-08-10 | Edwards Lifesciences Corporation | Expandable heart valve coaptation device |
| WO2019112768A1 (en) * | 2017-12-07 | 2019-06-13 | Obalon Therapeutics, Inc. | Intragastric device with self-deflation |
| US20190192280A1 (en) * | 2017-12-21 | 2019-06-27 | Biosense Webster (Israel) Ltd. | System for Adjusting the Shape of a Breast Implant |
| WO2019165449A1 (en) | 2018-02-26 | 2019-08-29 | Allurion Technologies, Inc. | Automatic-sealing balloon-filling catheter system |
| CN112312863A (zh) | 2018-04-24 | 2021-02-02 | 拉古维尔·巴苏德 | 可取回的组织抓取装置、间隔物、人造瓣膜及相关方法 |
| CN112638464B (zh) | 2018-07-06 | 2021-12-14 | 阿勒里恩科技公司 | 二元流体控制阀系统 |
| EP3886774A4 (en) * | 2018-12-13 | 2022-09-28 | Allurion Technologies, Inc. | ENHANCED FLUID DELIVERY SYSTEM |
| DE102019003482A1 (de) * | 2019-05-16 | 2020-11-19 | Creative Balloons Gmbh | Ballon mit mehrlagigem Wandungsaufbau für die dynamische Dichtung von Orangen und Hohlräumen im Körper |
| CN110495976B (zh) * | 2019-08-16 | 2024-08-30 | 四川大学华西医院 | 一种预防esd术后食管腔狭窄的器械 |
| WO2021051182A1 (pt) * | 2019-09-20 | 2021-03-25 | Salles De Almeida Leonardo | Dispositivos e método para ajuste bidirecional de balões intragástricos e válvula de bloqueio |
| WO2021159094A1 (en) * | 2020-02-07 | 2021-08-12 | Allurion Technologies, Inc. | Fluid delivery catheter |
| IT202000009013A1 (it) * | 2020-04-27 | 2021-10-27 | Milano Politecnico | Dispositivo per il trattamento di emorragie uterine post partum |
| CN113291621B (zh) * | 2021-05-14 | 2022-07-19 | 深圳市京迈德医疗技术有限公司 | 一种外水封内溢气膨胀抗震型试剂盒 |
| CN116602807B (zh) * | 2023-05-22 | 2024-05-28 | 张勤生 | 一种胶囊式自产气胃减容减重气囊 |
Family Cites Families (144)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2183900A (en) | 1938-01-10 | 1939-12-19 | William J Voit | Inflation valve |
| US3788813A (en) | 1971-09-07 | 1974-01-29 | Gen Electric | Gas conditioning and analyzing system |
| US3788322A (en) | 1972-12-27 | 1974-01-29 | Alza Corp | Drug delivery device with means for maintaining device in environment of use |
| US3797492A (en) | 1972-12-27 | 1974-03-19 | Alza Corp | Device for dispensing product with directional guidance member |
| US3786813A (en) | 1972-12-27 | 1974-01-22 | Alza Corp | Drug delivery device with self actuated mechanism for retaining device in selected area |
| US4133315A (en) | 1976-12-27 | 1979-01-09 | Berman Edward J | Method and apparatus for reducing obesity |
| DE2721548C2 (de) | 1977-05-13 | 1982-11-04 | Friedrich Gerd 5000 Köln Lauterjung | Sonde |
| US4340626A (en) | 1978-05-05 | 1982-07-20 | Rudy Marion F | Diffusion pumping apparatus self-inflating device |
| US4246893A (en) | 1978-07-05 | 1981-01-27 | Daniel Berson | Inflatable gastric device for treating obesity |
| US4234454A (en) | 1979-07-27 | 1980-11-18 | Phillips Petroleum Company | Diolefin dimerization catalyst and method for producing nitrosyl halides of iron triad metals |
| US4899747A (en) | 1981-12-10 | 1990-02-13 | Garren Lloyd R | Method and appartus for treating obesity |
| US4416267A (en) | 1981-12-10 | 1983-11-22 | Garren Lloyd R | Method and apparatus for treating obesity |
| US4545367A (en) | 1982-07-16 | 1985-10-08 | Cordis Corporation | Detachable balloon catheter and method of use |
| US4485805A (en) | 1982-08-24 | 1984-12-04 | Gunther Pacific Limited Of Hong Kong | Weight loss device and method |
| EP0103481A1 (en) | 1982-09-14 | 1984-03-21 | Ainsworth Nominees Proprietary Limited | Treatment and reduction of obesity in humans |
| US4607618A (en) | 1983-02-23 | 1986-08-26 | Angelchik Jean P | Method for treatment of morbid obesity |
| US4517979A (en) | 1983-07-14 | 1985-05-21 | Cordis Corporation | Detachable balloon catheter |
| US4489440A (en) | 1983-10-14 | 1984-12-18 | Bear Medical Systems, Inc. | Pressure-compensated pneumatic speech simulator |
| US4560392A (en) | 1983-11-22 | 1985-12-24 | Basevi John L | Noise making balloon valve |
| JPS61100519A (ja) | 1984-10-23 | 1986-05-19 | Shin Etsu Chem Co Ltd | 医薬用硬質カプセル |
| US4723547A (en) | 1985-05-07 | 1988-02-09 | C. R. Bard, Inc. | Anti-obesity balloon placement system |
| GB8517092D0 (en) | 1985-07-05 | 1985-08-14 | Taylor T V | Artificial bezoar |
| AU598200B2 (en) | 1985-07-30 | 1990-06-21 | Advanced Cardiovascular Systems Inc. | Dual dilation catheter assembly and miniature balloon dilatation catheter for use therewith |
| DE3540936C1 (de) | 1985-11-19 | 1986-10-02 | Reinhard Dr.Med. Stricker | Intragastraler Ballon |
| US4694827A (en) | 1986-01-14 | 1987-09-22 | Weiner Brian C | Inflatable gastric device for treating obesity and method of using the same |
| US4739758A (en) | 1986-05-19 | 1988-04-26 | Criticare Systems, Inc. | Apparatus for stomach cavity reduction |
| IL78883A0 (en) | 1986-05-23 | 1986-09-30 | Omikron Scient Ltd | Device and method for treating a patient for obesity |
| US4718639A (en) | 1987-02-17 | 1988-01-12 | Sherwood Allen L | Tire valve bodies |
| US4812315A (en) | 1987-05-14 | 1989-03-14 | Tarabishi M Hisham | Diet pills |
| US4857029A (en) | 1987-07-07 | 1989-08-15 | Enviro-Spray Systems, Inc. | Balloon storage and inflation assembly |
| US4813934A (en) | 1987-08-07 | 1989-03-21 | Target Therapeutics | Valved catheter device and method |
| US5084061A (en) | 1987-09-25 | 1992-01-28 | Gau Fred C | Intragastric balloon with improved valve locating means |
| US4929214A (en) | 1987-11-02 | 1990-05-29 | Liebermann Ron B | Inflatable enclosure and means to inflate same |
| US5129915A (en) | 1988-07-05 | 1992-07-14 | Jose Cantenys | Intragastric balloon |
| US4925446A (en) | 1988-07-06 | 1990-05-15 | Transpharm Group Inc. | Removable inflatable intragastrointestinal device for delivering beneficial agents |
| ES2081372T3 (es) | 1989-06-28 | 1996-03-01 | David S Zimmon | Dispositivos de balon de taponamiento. |
| ATE91638T1 (de) | 1989-09-25 | 1993-08-15 | Schneider Usa Inc | Mehrschichtextrusion als verfahren zur herstellung von ballons zur gefaessplastik. |
| US5049106A (en) | 1990-06-04 | 1991-09-17 | Sunyong Kim | Self-contained, self-inflating novelty balloon |
| US5213141A (en) | 1990-10-26 | 1993-05-25 | Dorman Ira S | Debris collection and disposal system and method |
| US5728119A (en) | 1991-05-29 | 1998-03-17 | Origin Medsystems, Inc. | Method and inflatable chamber apparatus for separating layers of tissue |
| US7744617B2 (en) | 1991-05-29 | 2010-06-29 | Covidien Ag | Method and inflatable chamber apparatus for separating layers of tissue |
| US5234454A (en) | 1991-08-05 | 1993-08-10 | Akron City Hospital | Percutaneous intragastric balloon catheter and method for controlling body weight therewith |
| US5259399A (en) | 1992-03-02 | 1993-11-09 | Alan Brown | Device and method of causing weight loss using removable variable volume intragastric bladder |
| US5431917A (en) | 1992-10-08 | 1995-07-11 | Japan Elanco Company, Ltd. | Hard capsule for pharmaceutical drugs and method for producing the same |
| US5952065A (en) | 1994-08-31 | 1999-09-14 | Nike, Inc. | Cushioning device with improved flexible barrier membrane |
| US5852889A (en) | 1994-08-31 | 1998-12-29 | Rinaldi; Robert | Greeting card with self-inflating balloon |
| US5674239A (en) | 1995-02-21 | 1997-10-07 | Zadini; Filiberto P. | Intravaginal balloon for blood leakage prevention |
| ES2236435T3 (es) | 1996-01-11 | 2005-07-16 | C.R. Bard Inc. | Cabezal de retencion para conjunto de tubo para acceder al cuerpo. |
| US5817099A (en) | 1996-06-06 | 1998-10-06 | Skolik; Stephanie A. | Universal port/seal device for ocular surgery |
| IES73225B2 (en) | 1996-12-02 | 1997-05-21 | Michael Sinsteden | An attachment for power tools |
| US5938669A (en) | 1997-05-07 | 1999-08-17 | Klasamed S.A. | Adjustable gastric banding device for contracting a patient's stomach |
| US5868141A (en) | 1997-05-14 | 1999-02-09 | Ellias; Yakub A. | Endoscopic stomach insert for treating obesity and method for use |
| US5993473A (en) | 1997-11-19 | 1999-11-30 | Chan; Yung C. | Expandable body device for the gastric cavity and method |
| US6427089B1 (en) | 1999-02-19 | 2002-07-30 | Edward W. Knowlton | Stomach treatment apparatus and method |
| MXPA00001922A (es) | 2000-02-24 | 2002-03-08 | De Hayos Garza Andres | Cateter de balon intragastrico percutaneo para tratamiento de la obesidad. |
| FR2805986B1 (fr) | 2000-03-13 | 2002-10-11 | Districlass Madical | Dispositif intra-gastrique a volume variable |
| US6682473B1 (en) | 2000-04-14 | 2004-01-27 | Solace Therapeutics, Inc. | Devices and methods for attenuation of pressure waves in the body |
| US7470228B2 (en) | 2000-04-14 | 2008-12-30 | Attenuex Technologies, Inc. | Method of treating benign hypertrophy of the prostate |
| WO2002016001A2 (en) | 2000-08-21 | 2002-02-28 | Jerry White | Inflatable object and method of inflating |
| FR2813786B1 (fr) | 2000-09-11 | 2003-03-14 | Medical Innovation Dev | Procede et dispositif de commande du gonflement d'une enveloppe prothetique gonflable et prothese en faisant application |
| US6689141B2 (en) | 2000-10-18 | 2004-02-10 | Microvention, Inc. | Mechanism for the deployment of endovascular implants |
| US6579301B1 (en) | 2000-11-17 | 2003-06-17 | Syntheon, Llc | Intragastric balloon device adapted to be repeatedly varied in volume without external assistance |
| US7066945B2 (en) | 2001-05-17 | 2006-06-27 | Wilson-Cook Medical Inc. | Intragastric device for treating obesity |
| IL143259A (en) | 2001-05-20 | 2006-08-01 | Given Imaging Ltd | A method of moving a bone in the colon |
| US6627206B2 (en) | 2001-07-25 | 2003-09-30 | Greg A. Lloyd | Method and apparatus for treating obesity and for delivering time-released medicaments |
| ES2333414T3 (es) * | 2001-09-17 | 2010-02-22 | Durect Corporation | Dispositivo y metodo para la entrega precisa de un agente activo. |
| FR2834202B1 (fr) | 2001-12-28 | 2004-03-19 | Cie Euro Etude Rech Paroscopie | Ballon intra-gastrique a poches multiples, dispositif chirurgical d'expansion dudit ballon et procede de fabrication correspondant |
| US6733512B2 (en) | 2002-03-07 | 2004-05-11 | Mcghan Jim J. | Self-deflating intragastric balloon |
| US6746460B2 (en) * | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
| US20040044351A1 (en) | 2002-08-27 | 2004-03-04 | Gary Searle | Mechanical occluding device |
| US7033384B2 (en) | 2002-08-30 | 2006-04-25 | Satiety, Inc. | Stented anchoring of gastric space-occupying devices |
| EP1555970B1 (en) | 2002-11-01 | 2014-09-24 | Valentx, Inc. | Apparatus for treatment of morbid obesity |
| US6951675B2 (en) | 2003-01-27 | 2005-10-04 | Scimed Life Systems, Inc. | Multilayer balloon catheter |
| US20080051866A1 (en) | 2003-02-26 | 2008-02-28 | Chao Chin Chen | Drug delivery devices and methods |
| US20060058829A1 (en) | 2003-03-19 | 2006-03-16 | Sampson Douglas C | Intragastric volume-occupying device |
| US6981980B2 (en) | 2003-03-19 | 2006-01-03 | Phagia Technology | Self-inflating intragastric volume-occupying device |
| EP1508349A1 (en) | 2003-08-18 | 2005-02-23 | Medtronic Vascular, Inc. | A hyper-elastic, high strength dilation balloon made from multi-block copolymers |
| US20050053648A1 (en) * | 2003-09-08 | 2005-03-10 | Chalmers Anne Marie | Medication delivery device |
| US20050075729A1 (en) | 2003-10-06 | 2005-04-07 | Nguyen Tuoc Tan | Minimally invasive valve replacement system |
| FR2866557B1 (fr) | 2004-02-20 | 2006-08-25 | Cie Euro Etude Rech Paroscopie | Ballon intra-gastrique a poche avec un organe d'obturation assemble de facon amelioree sur ladite poche |
| WO2005094257A2 (en) * | 2004-03-18 | 2005-10-13 | Inamed Medical Products Corporation | Apparatus and method for volume adjustment of intragastric balloons |
| US7883491B2 (en) | 2004-04-01 | 2011-02-08 | Shah Tilak M | Extrusion laminate polymeric film article and gastric occlusive device comprising same |
| EP1744804A4 (en) | 2004-05-03 | 2009-11-04 | Fulfillium Inc | METHOD AND SYSTEM FOR CONTROLLING GASTRIC VOLUME |
| US7112186B2 (en) | 2004-05-26 | 2006-09-26 | Shah Tilak M | Gastro-occlusive device |
| MX2007001819A (es) | 2004-08-13 | 2008-03-19 | Phagia Technology | Dispositivo que ocupa volumen intragastrico. |
| US20070078476A1 (en) | 2004-10-12 | 2007-04-05 | Hull Wendell C Sr | Overweight control apparatuses for insertion into the stomach |
| US7699863B2 (en) | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
| US7785291B2 (en) | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
| US7985199B2 (en) | 2005-03-17 | 2011-07-26 | Unomedical A/S | Gateway system |
| ES2351762T3 (es) * | 2005-06-01 | 2011-02-10 | Compagnie Européenne D' Etude Et De Recherche De Dispositifs Pour L'implantation Par Laparoscopie | Balón intragástrico provisto de una válvula que contiene un gel y kit. |
| PL1893141T3 (pl) * | 2005-06-01 | 2009-05-29 | Compagnie Europeenne Detude Et De Rech De Dispositifs Pour Limplantation Par Laparoscopie | Balon gastryczny z zaworem o podwójnej błonie oraz odpowiedni zestaw umieszczający |
| US20070100369A1 (en) | 2005-10-31 | 2007-05-03 | Cragg Andrew H | Intragastric space filler |
| US7879355B2 (en) | 2005-11-08 | 2011-02-01 | Plensat Llc | Method and system for treatment of eating disorders |
| US7674396B2 (en) | 2005-11-08 | 2010-03-09 | Plensat Llc | Method and system for treatment of eating disorders |
| US20070207199A1 (en) | 2005-12-28 | 2007-09-06 | Sogin Stephen J | Appetite suppression device |
| US8152710B2 (en) | 2006-04-06 | 2012-04-10 | Ethicon Endo-Surgery, Inc. | Physiological parameter analysis for an implantable restriction device and a data logger |
| US8070768B2 (en) | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
| US8342183B2 (en) | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
| US8858855B2 (en) | 2006-04-20 | 2014-10-14 | Boston Scientific Scimed, Inc. | High pressure balloon |
| WO2007136735A2 (en) | 2006-05-18 | 2007-11-29 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric and non-gastric implants |
| US20070288033A1 (en) * | 2006-06-09 | 2007-12-13 | Allergan, Inc. | Intragastric balloon retrieval mechanisms |
| TWI319617B (en) | 2006-09-12 | 2010-01-11 | Holtek Semiconductor Inc | Fuse option circuit |
| US9326877B2 (en) | 2006-09-29 | 2016-05-03 | Apollo Endosurgery, Inc. | Apparatus and method for intragastric balloon with in situ adjustment means |
| US7753949B2 (en) | 2007-02-23 | 2010-07-13 | The Trustees Of The University Of Pennsylvania | Valve prosthesis systems and methods |
| WO2008112894A1 (en) | 2007-03-15 | 2008-09-18 | Jiayi Li | Devices, systems, kits and methods for treatment of obesity |
| US20080255601A1 (en) * | 2007-04-13 | 2008-10-16 | Allergan, Inc. | Apparatus and method for remote deflation of intragastric balloon |
| US20080306506A1 (en) | 2007-06-11 | 2008-12-11 | Leatherman Dennis A | Self-inflating and deflating intragastric balloon implant device |
| US20090105687A1 (en) | 2007-10-05 | 2009-04-23 | Angioscore, Inc. | Scoring catheter with drug delivery membrane |
| FR2922095B1 (fr) | 2007-10-16 | 2010-09-03 | Cie Euro Etude Rech Paroscopie | Dispositif de gonflage d'un implant chirurgical |
| AU2008317024A1 (en) | 2007-10-23 | 2009-04-30 | Allergan, Inc. | Pressure sensing intragastric balloon |
| WO2009059802A1 (en) * | 2007-11-09 | 2009-05-14 | Venera Khafizova | Self-deflating gastric balloon device |
| WO2009059803A1 (en) | 2007-11-09 | 2009-05-14 | Venera Khafizova | Externally inflatable gastric balloon device |
| JP2009134178A (ja) * | 2007-11-30 | 2009-06-18 | Fujifilm Corp | カラーフィルタ及びそれを用いた液晶表示装置 |
| US8287562B2 (en) | 2007-12-20 | 2012-10-16 | 7L, Llc | Swallowable self-expanding gastric space occupying device |
| EP3572044B1 (en) | 2008-01-24 | 2021-07-28 | Medtronic, Inc. | Stents for prosthetic heart valves |
| CN100591289C (zh) | 2008-03-19 | 2010-02-24 | 王黎明 | 消化管腔内自充气气囊 |
| US20090259246A1 (en) | 2008-04-14 | 2009-10-15 | Sherif Eskaros | Intragastric Volume-Occupying Device |
| WO2010045477A2 (en) | 2008-10-16 | 2010-04-22 | Obalon Therapeutics, Inc. | Intragastric volume-occupying device and method for fabricating same |
| US20100100115A1 (en) | 2008-10-20 | 2010-04-22 | Wilson-Cook Medical Inc. | Foam filled intragastric balloon for treating obesity |
| EP2367503A1 (en) | 2008-11-25 | 2011-09-28 | AttenueX Technologies, Inc. | Implant with high vapor pressure medium |
| WO2010075482A2 (en) | 2008-12-27 | 2010-07-01 | John Hancock | High specific gravity intragastric device |
| FR2941617B1 (fr) * | 2009-02-04 | 2012-06-29 | Endalis | Ballon intra-gastrique. |
| JP2011135178A (ja) | 2009-12-22 | 2011-07-07 | Toyota Motor Corp | 音響装置、音響システム及び音声信号制御方法 |
| CN102905753B (zh) | 2009-12-24 | 2016-06-29 | 因卡伯实验室有限责任公司 | 可吞咽式药剂递送装置和药剂递送方法 |
| US8562589B2 (en) | 2009-12-24 | 2013-10-22 | Rani Therapeutics, Llc | Swallowable drug delivery device and method of delivery |
| US9504572B2 (en) | 2010-02-17 | 2016-11-29 | Medtronic Vascular, Inc. | Apparatus and methods for creating a venous valve from autologous tissue |
| US8870966B2 (en) | 2010-10-18 | 2014-10-28 | Apollo Endosurgery, Inc. | Intragastric balloon for treating obesity |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9149617B2 (en) | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US8809271B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8764733B2 (en) | 2010-12-23 | 2014-07-01 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8292911B2 (en) | 2011-01-21 | 2012-10-23 | Obalon Therapeutics, Inc. | Intragastric device |
| US8202291B1 (en) | 2011-01-21 | 2012-06-19 | Obalon Therapeutics, Inc. | Intragastric device |
| US8647358B2 (en) | 2011-01-21 | 2014-02-11 | Obalon Therapeutics Inc. | Intragastric device |
| PT2665512T (pt) | 2011-01-21 | 2016-08-29 | Obalon Therapeutics Inc | Dispositivo intragástrico |
| US20130226219A1 (en) | 2011-01-21 | 2013-08-29 | Obalon Therapeutics, Inc. | Intragastric device |
| WO2012158972A2 (en) | 2011-05-17 | 2012-11-22 | Endobese, Inc. | Method and apparatus for buoyant gastric implant |
| US20130267983A1 (en) | 2012-04-05 | 2013-10-10 | Allergan, Inc. | Intragastric balloon shell materials and construction |
| AU2013381897B2 (en) | 2013-03-15 | 2018-04-19 | Obalon Therapeutics, Inc. | Intragastric device |
| US9706824B2 (en) | 2013-11-06 | 2017-07-18 | Christopher Tuning | Hat storage device |
| US20160257911A1 (en) | 2015-03-06 | 2016-09-08 | Flotek Chemistry, Llc | Compositions and methods for cleaning a surface and other applications |
| US10537453B2 (en) | 2015-12-16 | 2020-01-21 | Obalon Therapeutics, Inc. | Intragastric device with expandable portions |
| CN106611170B (zh) | 2017-01-03 | 2021-10-22 | 京东方科技集团股份有限公司 | 指纹识别装置及电子设备 |
-
2011
- 2011-01-21 PT PT118563477T patent/PT2665512T/pt unknown
- 2011-01-21 PT PT161764055T patent/PT3117865T/pt unknown
- 2011-01-21 EP EP11856347.7A patent/EP2665512B1/en active Active
- 2011-01-21 KR KR1020177012338A patent/KR101806089B1/ko active IP Right Grant
- 2011-01-21 HU HUE16176405A patent/HUE035460T2/en unknown
- 2011-01-21 WO PCT/US2011/022165 patent/WO2012099609A1/en active Application Filing
- 2011-01-21 KR KR1020157005842A patent/KR101805995B1/ko active IP Right Grant
- 2011-01-21 DK DK16176405.5T patent/DK3117865T3/da active
- 2011-01-21 EP EP16176405.5A patent/EP3117865B9/en active Active
- 2011-01-21 EP EP17192067.1A patent/EP3284504B1/en active Active
- 2011-01-21 NO NO16176405A patent/NO3117865T3/no unknown
- 2011-01-21 HU HUE11856347A patent/HUE029644T2/en unknown
- 2011-01-21 ES ES16176405.5T patent/ES2653806T3/es active Active
- 2011-01-21 BR BR112013018254-7A patent/BR112013018254B1/pt active IP Right Grant
- 2011-01-21 KR KR1020127033004A patent/KR101500055B1/ko active IP Right Grant
- 2011-01-21 EP EP20173235.1A patent/EP3769808A3/en not_active Withdrawn
- 2011-01-21 US US13/510,921 patent/US8740927B2/en active Active
- 2011-01-21 DK DK11856347.7T patent/DK2665512T3/da active
- 2011-01-21 MX MX2013008341A patent/MX345691B/es active IP Right Grant
- 2011-01-21 KR KR1020147021216A patent/KR101724810B1/ko active IP Right Grant
- 2011-01-21 ES ES11856347.7T patent/ES2585428T3/es active Active
-
2012
- 2012-01-20 AR ARP120100193A patent/AR085085A1/es active IP Right Grant
-
2014
- 2014-03-27 US US14/227,195 patent/US9351862B2/en active Active
-
2015
- 2015-09-21 US US14/860,538 patent/US9827128B2/en active Active
-
2016
- 2016-05-04 US US15/146,832 patent/US9662239B2/en active Active
-
2017
- 2017-08-29 US US15/690,095 patent/US10463520B2/en active Active
-
2018
- 2018-02-27 US US15/906,942 patent/US10610396B2/en active Active
-
2020
- 2020-02-14 US US16/792,094 patent/US11737899B2/en active Active
-
2022
- 2022-01-21 US US17/581,792 patent/US11779482B2/en active Active
-
2023
- 2023-08-31 US US18/241,151 patent/US20230414391A1/en active Pending
- 2023-09-20 US US18/370,819 patent/US11974934B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11974934B2 (en) | Intragastric device | |
| US20220105323A1 (en) | Intragastric device | |
| US9173758B2 (en) | Intragastric device | |
| AU2018202859B2 (en) | Intragastric device | |
| US10660778B2 (en) | Systems and methods for enabling passage of an intragastric device |